{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:45:28Z","timestamp":1785386728164,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Danish Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autoantibodies have the potential as cancer biomarkers as they may associate with the outcome and immune-related adverse events (irAEs) following immunotherapy. Cancer and other fibroinflammatory diseases, such as rheumatoid arthritis (RA), are associated with excessive collagen turnover leading to collagen triple helix unfolding and denaturation with exposure of immunodominant epitopes. In this study, we aimed to investigate the role of autoreactivity against denatured collagen in cancer. A technically robust assay to quantify autoantibodies against denatured type III collagen products (anti-dCol3) was developed and then measured in pretreatment serum from 223 cancer patients and 33 age-matched controls. Moreover, the association between anti-dCol3 levels and type III collagen degradation (C3M) and formation (PRO-C3) was investigated. Anti-dCol3 levels were significantly lower in patients with bladder (p = 0.0007), breast (p = 0.0002), colorectal (p &lt; 0.0001), head and neck (p = 0.0005), kidney (p = 0.005), liver (p = 0.030), lung (p = 0.0004), melanoma (p &lt; 0.0001), ovarian (p &lt; 0.0001), pancreatic (p &lt; 0.0001), prostate (p &lt; 0.0001), and stomach cancers (p &lt; 0.0001) compared to controls. High anti-dCol3 levels were associated with type III collagen degradation (C3M, p = 0.0002) but not type III collagen formation (PRO-C3, p = 0.26). Cancer patients with different solid tumor types have downregulated levels of circulating autoantibodies against denatured type III collagen compared to controls, suggesting that autoreactivity against unhealthy type III collagen may be important for tumor control and eradication. This autoimmunity biomarker may have the potential for studying the close relationship between autoimmunity and cancer.<\/jats:p>","DOI":"10.3390\/ijms24087067","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T02:57:08Z","timestamp":1681268228000},"page":"7067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Autoreactivity against Denatured Type III Collagen Is Significantly Decreased in Serum from Patients with Cancer Compared to Healthy Controls"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-7307","authenticated-orcid":false,"given":"Christina","family":"Jensen","sequence":"first","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Drobinski","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-0786","authenticated-orcid":false,"given":"Jeppe","family":"Thorlacius-Ussing","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-9297","authenticated-orcid":false,"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Willumsen","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102706","DOI":"10.1016\/j.autrev.2020.102706","article-title":"Profiling and targeting connective tissue remodeling in autoimmunity\u2014A novel paradigm for diagnosing and treating chronic diseases","volume":"20","author":"Karsdal","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1021\/acsnano.7b03150","article-title":"In Situ Imaging of Tissue Remodeling with Collagen Hybridizing Peptides","volume":"11","author":"Hwang","year":"2017","journal-title":"ACS Nano"},{"key":"ref_4","first-page":"1","article-title":"Efficacy of Oral Collagen in Joint Pain\u2014Osteoarthritis and Rheumatoid Arthritis","volume":"6","author":"Woo","year":"2017","journal-title":"J. Arthritis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1002\/jcp.29752","article-title":"Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis","volume":"235","author":"Han","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of Autoantibody-Induced Pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00296-013-2731-2","article-title":"T cell responses to citrullinated self-peptides in patients with rheumatoid arthritis","volume":"33","author":"Aggarwal","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/intimm\/dxy042","article-title":"Immune suppression and reversal of the suppressive tumor microenvironment","volume":"30","author":"Shimizu","year":"2018","journal-title":"Int. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Seliger, B., and Massa, C. (2021). Immune Therapy Resistance and Immune Escape of Tumors. Cancers, 13.","DOI":"10.3390\/cancers13030551"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3892\/or.2012.2197","article-title":"Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR\/ErbB2 receptors in prostate cancer patients","volume":"29","author":"Ingrosso","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_11","first-page":"121","article-title":"Autoimmunity to collagen in human lung cancer","volume":"56","author":"Karvonen","year":"1996","journal-title":"Cancer Res."},{"key":"ref_12","unstructured":"FDA, and CDER (2018). Bioanalytical Method Validation Guidance for Industry, Biopharmaceutics Bioanalytical Method Validation Guidance for Industry Biopharmaceutics Contains Nonbinding Recommendations."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","article-title":"A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen","volume":"43","author":"Barascuk","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF02239196","article-title":"Anticollagen antibodies in patients with juvenile chronic arthritis","volume":"7","author":"Havelka","year":"1988","journal-title":"Clin. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM197808172990703","article-title":"Cellular Sensitivity to Collagen in Rheumatoid Arthritis","volume":"299","author":"Trentham","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JHC.S275008","article-title":"Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma\u2014A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients","volume":"ume 7","author":"Jensen","year":"2020","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1002\/ijc.32751","article-title":"Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer","volume":"146","author":"Chen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19761","DOI":"10.1038\/s41598-019-56268-3","article-title":"Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer","volume":"9","author":"Willumsen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3389\/fimmu.2020.02139","article-title":"Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review","volume":"11","author":"Reyneveld","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.semcancer.2019.08.001","article-title":"Immune-checkpoint inhibitors for the treatment of metastatic melanoma: A model of cancer immunotherapy","volume":"59","author":"Queirolo","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Brahmer","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41698-021-00223-x","article-title":"Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types","volume":"5","author":"Wang","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"ref_25","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am. J. Transl. Res."},{"key":"ref_26","unstructured":"(2023, April 04). Abcam. Available online: https:\/\/www.abcam.com\/products\/secondary-antibodies\/mouse-monoclonal-jdc-10-human-igg-fc-hrp-ab99759.html."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study","volume":"69","author":"Jones","year":"2009","journal-title":"Ann. Rheum. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:13:58Z","timestamp":1760123638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24087067"],"URL":"https:\/\/doi.org\/10.3390\/ijms24087067","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]}}}